Literature DB >> 15094168

Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production.

Sandra Gomes-Pereira1, Olivia Roos Rodrigues, Nuno Rolão, Paulo David Almeida, Gabriela Maria Santos-Gomes.   

Abstract

The objective of this study was to analyse hepatic cellular immune response of mice with "cure" and "non-cure" phenotypes to Leishmania infantum infection. During infection establishment, elevated TGF-beta levels and absence of a Th1 response may have contributed to parasite multiplication and to similar hepatic parasitic loads. Later in infection, an increase in the number and activation levels of CD8+ cells was observed simultaneously with parasite elimination, but only significant in "cure" strain. During this recovering phase, "non-cure" animals showed low Th2 cytokine levels, while TGF-beta production was higher than in "cure" mice. These results point out to a role for CD8+ T cells in liver acquired immune response and to TGF-beta regulation of "cure" and "non-cure" phenotype to L. infantum infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094168     DOI: 10.1016/j.femsim.2004.01.003

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  8 in total

1.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

3.  Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.

Authors:  S Rama Iñiguez; M A Dea-Ayuela; J A Sanchez-Brunete; J J Torrado; J M Alunda; F Bolas-Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice.

Authors:  Gaurav Gupta; Saikat Majumdar; Anupam Adhikari; Parna Bhattacharya; Asok Kumar Mukherjee; Suchandra Bhattacharyya Majumdar; Subrata Majumdar
Journal:  Med Microbiol Immunol       Date:  2011-05-01       Impact factor: 3.402

5.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

6.  Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.

Authors:  Florence Robert-Gangneux; Anne-Sophie Drogoul; Octavie Rostan; Claire Piquet-Pellorce; Jérome Cayon; Mariette Lisbonne; André Herbelin; Hugues Gascan; Claude Guiguen; Michel Samson; Jean-Pierre Gangneux
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

7.  Antigen-Pulsed CpG-ODN-Activated Dendritic Cells Induce Host-Protective Immune Response by Regulating the T Regulatory Cell Functioning in Leishmania donovani-Infected Mice: Critical Role of CXCL10.

Authors:  Saikat Majumder; Amrita Bhattacharjee; Bidisha Paul Chowdhury; Suchandra Bhattacharyya Majumdar; Subrata Majumdar
Journal:  Front Immunol       Date:  2014-06-04       Impact factor: 7.561

Review 8.  Study of Leishmania pathogenesis in mice: experimental considerations.

Authors:  Corinne Loeuillet; Anne-Laure Bañuls; Mallorie Hide
Journal:  Parasit Vectors       Date:  2016-03-11       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.